United Therapeutics CorporationUTHRNASDAQ
LOADING
|||
Year-over-year revenue growth rate
| Period | Value |
|---|---|
| Q3 2025 | 0.11% |
| Q2 2025 | 0.53% |
| Q1 2025 | 7.95% |
| Q4 2024 | -1.74% |
| Q3 2024 | 4.76% |
| Q2 2024 | 5.49% |
| Q1 2024 | 10.25% |
| Q4 2023 | 0.87% |
| Q3 2023 | 2.16% |
| Q2 2023 | 17.68% |
| Q1 2023 | 3.13% |
| Q4 2022 | -4.75% |
| Q3 2022 | 10.52% |
| Q2 2022 | 1.08% |
| Q1 2022 | 11.25% |
| Q4 2021 | -6.63% |
| Q3 2021 | -0.40% |
| Q2 2021 | 17.78% |
| Q1 2021 | -1.51% |
| Q4 2020 | 1.26% |
| Q3 2020 | 5.00% |
| Q2 2020 | 1.60% |
| Q1 2020 | 14.53% |
| Q4 2019 | -22.52% |
| Q3 2019 | 7.47% |
| Q2 2019 | 3.03% |
| Q1 2019 | -4.93% |
| Q4 2018 | -7.58% |
| Q3 2018 | -7.15% |
| Q2 2018 | 14.21% |
| Q1 2018 | -16.25% |
| Q4 2017 | 4.31% |
| Q3 2017 | 0.20% |
| Q2 2017 | 20.00% |
| Q1 2017 | -9.41% |
| Q4 2016 | 0.20% |
| Q3 2016 | -1.07% |
| Q2 2016 | 11.82% |
| Q1 2016 | -8.86% |
| Q4 2015 | 4.83% |